Danny Galleguillos

Edmonton, AB, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Author Correction: Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos.

Author Correction: Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos.

Journal: Nature neuroscience
Published: March 11, 2026

Native PLGA nanoparticles attenuate disease pathology via multiple pathways in 5xFAD Alzheimer's model.

Native PLGA nanoparticles attenuate disease pathology via multiple pathways in 5xFAD Alzheimer's model.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: June 24, 2025

Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos.

Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos.

Journal: Nature neuroscience
Published: November 23, 2024

MHC class I and II expression and induction in oligodendrocytes varies with age.

MHC class I and II expression and induction in oligodendrocytes varies with age.

Journal: Scientific reports
Published: November 16, 2024

NLRX1 limits inflammatory neurodegeneration in the anterior visual pathway.

NLRX1 limits inflammatory neurodegeneration in the anterior visual pathway.

Journal: Journal of neuroinflammation
Published: August 21, 2024

Pharmacological modulation of inflammatory oligodendrocyte progenitor cells using three multiple sclerosis disease modifying therapies in vitro.

Pharmacological modulation of inflammatory oligodendrocyte progenitor cells using three multiple sclerosis disease modifying therapies in vitro.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: December 05, 2023

The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives.

The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: May 13, 2023

Naïve Huntington's disease microglia mount a normal response to inflammatory stimuli but display a partially impaired development of innate immune tolerance that can be counteracted by ganglioside GM1.

Naïve Huntington's disease microglia mount a normal response to inflammatory stimuli but display a partially impaired development of innate immune tolerance that can be counteracted by ganglioside GM1.

Journal: Journal of neuroinflammation
Published: March 07, 2023

Fractalkine enhances oligodendrocyte regeneration and remyelination in a demyelination mouse model.

Fractalkine enhances oligodendrocyte regeneration and remyelination in a demyelination mouse model.

Journal: Stem cell reports
Published: March 14, 2022

Anti-inflammatory role of GM1 and other gangliosides on microglia.

Anti-inflammatory role of GM1 and other gangliosides on microglia.

Journal: Journal of neuroinflammation
Published: August 19, 2021

Fractalkine signaling regulates oligodendroglial cell genesis from SVZ precursor cells.

Fractalkine signaling regulates oligodendroglial cell genesis from SVZ precursor cells.

Journal: Stem cell reports
Published: December 02, 2020

Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications.

Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications.

Journal: Frontiers in neuroscience
Published: June 15, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026